Gentamicin Intravesical Efficacy for Infection of Urinary Tract

PHASE2CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

January 29, 2020

Primary Completion Date

December 5, 2021

Study Completion Date

December 5, 2021

Conditions
Postoperative Urinary Tract InfectionPelvic Organ ProlapseStress Urinary Incontinence
Interventions
DRUG

gentamicin sulfate

Subjects in the gentamicin arm will receive an bladder instillation of 80mg of gentamicin sulfate in 50 mL of normal saline through a standard-of-care Foley catheter.

OTHER

Catheter clamping only

Subjects in the control arm will have their standard-of-care transurethral catheter clamped for 1 hour post-placement to maintain subject masking to study arm.

Trial Locations (2)

92037

UC San Diego Health, La Jolla

92123

Kaiser Permanente San Diego, San Diego

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

lead

Kaiser Permanente

OTHER

NCT04246996 - Gentamicin Intravesical Efficacy for Infection of Urinary Tract | Biotech Hunter | Biotech Hunter